Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RETORIN POWDER FOR SUSPENSION 200 mg/5 ml - HSA Drug Approval Details

Approvals/HSA/RETORIN POWDER FOR SUSPENSION 200 mg/5 ml

Approved

THERAPEUTIC

RETORIN POWDER FOR SUSPENSION 200 mg/5 ml

SM PHARMACEUTICALS SDN BHD🇸🇬 Health Sciences Authority

Approval Date: Dec 16, 1999
Approval ID: 4608ac8f8854f231
Company: SM PHARMACEUTICALS SDN BHD
Type: Therapeutic

Approval Details

Approval Id: 4608ac8f8854f231
Drug Name: RETORIN POWDER FOR SUSPENSION 200 mg/5 ml
Product Name: RETORIN POWDER FOR SUSPENSION 200 mg/5 ml
Approval Number: SIN11245P
Approval Date: 1999-12-16
Registrant: UNI DRUG HOUSE
Licence Holder: UNI DRUG HOUSE
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: POWDER, FOR SUSPENSION
Route Of Administration: ORAL
Atc Code: J01FA01
Atc Item Name: erythromycin
Pharma Manufacturer Name: UNI DRUG HOUSE SDN. BHD.
Company Detail Path: /organization/uni-drug-house-sdn-bhd

Active Ingredients

ERYTHROMYCIN ETHYLSUCCINATE EQV ERYTHROMYCIN

200 mg/5 ml

ERYTHROMYCIN ETHYLSUCCINATE EQV ERYTHROMYCIN

200 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Dec 16, 1999

Approval ID

4608ac8f8854f231

Type

Therapeutic

Back to HSA Approvals